{"id":"https://openalex.org/W4416630006","doi":"https://doi.org/10.1158/1078-0432.30709266","title":"Supplementary Data 1 from Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma","display_name":"Supplementary Data 1 from Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416630006","doi":"https://doi.org/10.1158/1078-0432.30709266"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30709266","doi":"https://doi.org/10.1158/1078-0432.30709266","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709266","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30709266","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043675371","display_name":"Vivek Subbiah","orcid":"https://orcid.org/0000-0002-6064-6837","observed_orcids":["https://orcid.org/0000-0002-6064-6837"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivek Subbiah","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6064-6837","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073906112","display_name":"Sant P. Chawla","orcid":"https://orcid.org/0000-0002-9522-6744","observed_orcids":["https://orcid.org/0000-0002-9522-6744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sant P. Chawla","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9522-6744","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089849331","display_name":"Anthony Paul Conley","orcid":"https://orcid.org/0000-0002-6232-1163","observed_orcids":["https://orcid.org/0000-0002-6232-1163"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony P. Conley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6232-1163","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004799762","display_name":"Breelyn Ann Wilky","orcid":"https://orcid.org/0000-0001-5080-497X","observed_orcids":["https://orcid.org/0000-0001-5080-497X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Breelyn A. Wilky","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5080-497X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Tolcher","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6322-9721","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003770647","display_name":"Nehal J. Lakhani","orcid":"https://orcid.org/0009-0005-6327-0176","observed_orcids":["https://orcid.org/0009-0005-6327-0176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nehal J. Lakhani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-6327-0176","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029460219","display_name":"David Berz","orcid":"https://orcid.org/0000-0001-8368-4601","observed_orcids":["https://orcid.org/0000-0001-8368-4601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Berz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8368-4601","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004218727","display_name":"Vasily Andrianov","orcid":"https://orcid.org/0009-0005-1895-9126","observed_orcids":["https://orcid.org/0009-0005-1895-9126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vasily Andrianov","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-1895-9126","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021653238","display_name":"William Crago","orcid":"https://orcid.org/0009-0000-5838-4295","observed_orcids":["https://orcid.org/0009-0000-5838-4295"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Crago","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-5838-4295","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065492320","display_name":"Monica Holcomb","orcid":"https://orcid.org/0009-0005-5298-7147","observed_orcids":["https://orcid.org/0009-0005-5298-7147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Holcomb","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5298-7147","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001672585","display_name":"Abrahim Hussain","orcid":"https://orcid.org/0009-0000-3615-2581","observed_orcids":["https://orcid.org/0009-0000-3615-2581"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abrahim Hussain","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-3615-2581","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038102558","display_name":"Carson Veldstra","orcid":"https://orcid.org/0009-0001-2809-0234","observed_orcids":["https://orcid.org/0009-0001-2809-0234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carson Veldstra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-2809-0234","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004637134","display_name":"James L. Kalabus","orcid":"https://orcid.org/0000-0001-7582-8601","observed_orcids":["https://orcid.org/0000-0001-7582-8601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Kalabus","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7582-8601","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020727952","display_name":"Brianne O\u2019Neill","orcid":"https://orcid.org/0009-0008-9224-952X","observed_orcids":["https://orcid.org/0009-0008-9224-952X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brianne O\u2019Neill","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-9224-952X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092070894","display_name":"Lane Senne","orcid":"https://orcid.org/0009-0005-3531-5840","observed_orcids":["https://orcid.org/0009-0005-3531-5840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lane Senne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-3531-5840","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060971964","display_name":"Emily A. Rowell","orcid":"https://orcid.org/0009-0000-2630-2179","observed_orcids":["https://orcid.org/0009-0000-2630-2179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Rowell","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-2630-2179","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075481772","display_name":"Analeah B. Heidt","orcid":"https://orcid.org/0009-0002-1096-7760","observed_orcids":["https://orcid.org/0009-0002-1096-7760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Analeah B. Heidt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1096-7760","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044683914","display_name":"Katelyn M. Willis","orcid":"https://orcid.org/0009-0004-5741-4076","observed_orcids":["https://orcid.org/0009-0004-5741-4076"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katelyn M. Willis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-5741-4076","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064638988","display_name":"Brendan P. Eckelman","orcid":"https://orcid.org/0009-0006-7090-2642","observed_orcids":["https://orcid.org/0009-0006-7090-2642"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brendan P. Eckelman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-7090-2642","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.5239999890327454},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7730000019073486},{"id":"https://openalex.org/keywords/chondrosarcoma","display_name":"chondrosarcoma","score":0.9710000157356262},{"id":"https://openalex.org/keywords/preclinical-characterization","display_name":"preclinical characterization","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7717999815940857},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6069999933242798},{"id":"https://openalex.org/C2776302905","wikidata":"https://www.wikidata.org/wiki/Q1076087","display_name":"Chondrosarcoma","level":2,"score":0.5753999948501587},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5339999794960022},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4722999930381775},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4271000027656555},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42100000381469727},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.31029999256134033},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.28600001335144043},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.2802000045776367},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27410000562667847},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26649999618530273}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30709266","doi":"https://doi.org/10.1158/1078-0432.30709266","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709266","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30709266","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_1_from_Preclinical_Characterization_and_Phase_I_Trial_Results_of_INBRX-109_A_Third-Generation_Recombinant_Humanized_Death_Receptor_5_Agonist_Antibody_in_Chondrosarcoma/30709266","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30709266","doi":"https://doi.org/10.1158/1078-0432.30709266","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709266","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385836516","https://openalex.org/W4379094382","https://openalex.org/W4402797938","https://openalex.org/W4281808436","https://openalex.org/W7131104595","https://openalex.org/W7165047867","https://openalex.org/W7165055846","https://openalex.org/W7164992961","https://openalex.org/W7164988232","https://openalex.org/W7165027067"],"abstract_inverted_index":{"Supplementary":[0],"Tables,":[1],"Figures,":[2],"and":[3],"References":[4]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-11-25T00:00:00"}